Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method

Benzer Materyaller

• Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012
  Yazar:: Sader, Helio S., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
  Yazar:: Farrell, David J., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
  Yazar:: Pfaller, Michael A., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015
  Yazar:: Sader, Helio S., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013
  Yazar:: Sader, Helio S., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)